Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Schimmel currently holds 1,413,023 shares of aTYR PHARMA INC (ATYR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Schimmel has been a net seller of ATYR stock. They have purchased $9.2M and sold $16.7M worth of shares.
Paul Schimmel's most recent insider trade was on Oct 9, 2025, when they purchased 317,999 shares at $0.94 per share.
Paul Schimmel serves as Executive at aTYR PHARMA INC (ATYR). They have executed 129 insider transactions totaling $25.9M over their tenure at the company.
Paul Schimmel holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Paul Schimmel has shown a selling trading pattern, with $9.2M in total purchases and $16.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Schimmel was on Mar 13, 2018, when they sold $4.2M worth of ALNY shares. This transaction involved 27,823 shares at $150.00 per share.
Paul Schimmel currently owns 1,413,023 shares of aTYR PHARMA INC (ATYR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Schimmel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Schimmel has 129 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for Paul Schimmel and 40,000+ other insiders.